Pharmaceutical Drug Regulations and Registration Process to Russia
Abstract
Commonwealth of Independent States (CIS) has been identified to be one of emerging markets due to the phenomenal growth of the pharmaceutical industry. It has been estimated that pharmaceutical sector in Russia and other CIS nations with CAGR of 10 to 11% during the year 2012–2016. Russia holds 14% of CIS market in 2013. The choice of Russia as one of the destination for the market of the drug products ensures the manufacturer a good market value. Russia is considered as one of the strongest and promised markets for the registration of the drugs In Russia Roszdravnadzor, coming under the purview of Ministry of Health takes the decision to register the product and issues registration certificate. The format for pharmaceutical registration is common technical document (CTD). India and Russia have signed a memorandum of understanding (MoU) in 2010 for cooperation in the pharmaceutical trade and industry and have implemented the memorandum of understanding (MoU). Thus the paper focuses mainly on the registration process involved labelling of Russian Federation, regulatory authority of Russian Federation and scope of Indian pharmaceutical companies in the Russian market.
Keywords: Russia, CIS, MoU, CTD, dossier
Cite this Article
Rahman Fijaz, Dixit Mudit. Pharmaceutical drug regulations and registration process to Russia. Trends in Drug Delivery. 2015; 2(2): 8–18p.
Downloads
Published
Issue
Section
License
Copyright Transfer and Declaration Form (Please compile this form, sign and send by e-mail and post)
Journal Title:
Title of the Paper:
Corresponding Author’s Information: Name: Address:
E-mail:
Contact Number: I
t is herein agreed that: The copyright to the above-listed unpublished and original article is transferred to STM Journals. This copyright transfer covers the exclusive right to reproduce and distribute the contribution, including reprints, translations, photographic reproductions, microform, electronic form (offline, online), or any other reproductions of similar nature. I/We declare that above manuscript is not published already in part or whole (except in the form of abstract) in any journal or magazine for private or public circulation, and, is not under consideration of publication elsewhere. I/ We warrant(s) that his/her/their contribution is original, except for such excerpts from copyrighted works as may be included with the permission of the copyright holder and author thereof, that it contains no libelous statements, and does not infringe on any copyright, trademark, patent, statutory right, or propriety right of others. I/We will not publish his/her/their above said contribution anywhere else without the prior written permission of the publisher unless it has been changed substantially.I/We also agree to the authorship of the article in the following order:Author(s) Name Signature(s)1. ________________2. ________________3. ________________4. ________________The author(s) agree to the terms of this Copyright Notice, which will apply to this submission if and when it is published by this journal (comments if any to the editor can be added below).
